Vurdering af reguleringsmæssige behov - liste
Vurdering af reguleringsmæssige behov - liste
The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed.
For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.
The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Last updated 03 maj 2024. Database contains 5017 unique substances/entries.
QUANTACURE QTX
|
402-200-7
|
103430-24-6
|
ECHA
|
Under development
|
Pending action
|
27-jun.-2022
|
Details | |
247-840-6
|
26603-40-7
|
ECHA
|
Under development
|
Pending action
|
16-jan.-2023
|
Details | ||
429-620-3
|
110028-14-3
|
ECHA
|
Under development
|
Pending action
|
11-dec.-2023
|
Details | ||
425-220-8
|
5945-33-5
|
ECHA
|
Under development
|
Pending action
|
16-dec.-2021
|
Details | ||
248-310-7
|
27193-28-8
|
ECHA
|
Under development
|
Pending action
|
11-sep.-2023
|
Details | ||
201-071-2
|
77-94-1
|
France
|
Endocrine disruption |
Concluded
|
Other legislation
|
30-sep.-2016
|
Details | |
203-625-9
|
108-88-3
|
ECHA
|
Under development
|
Other legislation
|
25-sep.-2023
|
Details | ||
207-995-2
|
504-60-9
|
Netherlands
|
Other environmental toxicity Other human toxicity |
Concluded
|
Other legislation
|
15-aug.-2017
|
Details | |
232-104-9
|
7786-81-4
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Other legislation
|
02-feb.-2017
|
Details | |
234-323-5
|
11099-02-8
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Other legislation
|
02-feb.-2017
|
Details | |
240-715-7
|
16669-59-3
|
Sweden
|
Carcinogenic Mutagenic |
Concluded
|
Other legislation
|
25-aug.-2021
|
Details | |
222-871-8
|
3644-11-9
|
Sweden
|
Carcinogenic Mutagenic |
Concluded
|
Other legislation
|
25-aug.-2021
|
Details | |
272-489-0
|
68855-54-9
|
Netherlands
|
Other environmental toxicity Other human toxicity Persistence Toxic for reproduction |
Concluded
|
Other legislation
|
15-dec.-2017
|
Details | |
202-849-4
|
100-41-4
|
ECHA
|
Under development
|
CLH Other legislation |
25-sep.-2023
|
Details | ||
231-892-1
|
7775-27-1
|
France
|
Respiratory sensitiser Skin sensitiser Toxic for reproduction |
Concluded
|
Other legislation
|
02-mar.-2020
|
Details | |
231-781-8
|
7727-21-1
|
France
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Other legislation
|
02-mar.-2020
|
Details | |
212-039-2
|
753-73-1
|
Netherlands
|
Other human toxicity |
Concluded
|
Other legislation
|
10-jul.-2015
|
Details | |
231-786-5
|
7727-54-0
|
France
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Other legislation
|
02-mar.-2020
|
Details | |
200-673-2
|
67-97-0
|
Netherlands
|
Bioaccumulation Persistence |
Pending
|
Other legislation
|
04-nov.-2022
|
Details | |
203-466-5
|
107-13-1
|
Germany
|
Mutagenic Other human toxicity Toxic for reproduction |
Concluded
|
Other legislation
|
23-sep.-2014
|
Details | |
220-239-6
|
2682-20-4
|
Denmark
|
Skin sensitiser |
Concluded
|
Other legislation
|
04-maj-2015
|
Details | |
260-829-0
|
57583-35-4
|
Netherlands
|
Bioaccumulation Other human toxicity Persistence |
Concluded
|
Other legislation
|
05-jul.-2017
|
Details | |
204-881-4
|
128-37-0
|
France
|
Carcinogenic Endocrine disruption Exposure Skin sensitiser |
Concluded
|
Other legislation
|
28-feb.-2017
|
Details | |
203-444-5
|
106-93-4
|
ECHA
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Other Other legislation |
07-aug.-2015
|
Details | |
205-288-3
|
137-30-4
|
ECHA
|
Under development
|
Other action
|
24-jun.-2021
|
Details | ||
236-144-8
|
13189-00-9
|
ECHA
|
Under development
|
Other action
|
08-jul.-2021
|
Details | ||
238-677-1
|
14634-93-6
|
ECHA
|
Under development
|
Other action
|
24-jun.-2021
|
Details | ||
239-370-5
|
15337-18-5
|
ECHA
|
Under development
|
Other action
|
24-jun.-2021
|
Details | ||
238-270-9
|
14324-55-1
|
ECHA
|
Under development
|
Other action
|
24-jun.-2021
|
Details | ||
205-232-8
|
136-23-2
|
ECHA
|
Under development
|
Other action
|
24-jun.-2021
|
Details | ||
238-778-0
|
14726-36-4
|
ECHA
|
Under development
|
Other action
|
24-jun.-2021
|
Details | ||
231-780-2
|
7727-18-6
|
ECHA
|
Under development
|
CLH Other action |
19-maj-2021
|
Details | ||
231-744-6
|
7718-98-1
|
ECHA
|
Under development
|
CLH Other action |
19-maj-2021
|
Details | ||
231-561-1
|
7632-51-1
|
ECHA
|
Under development
|
CLH Other action |
19-maj-2021
|
Details | ||
949-084-9
|
-
|
ECHA
|
Under development
|
CLH Other action |
19-maj-2021
|
Details | ||
248-652-7
|
27774-13-6
|
ECHA
|
Under development
|
CLH Other action |
19-maj-2021
|
Details | ||
618-920-1
|
93280-40-1
|
ECHA
|
Under development
|
CLH Other action |
19-maj-2021
|
Details | ||
468-740-0
|
-
|
ECHA
|
Under development
|
Other action Other action |
16-dec.-2021
|
Details | ||
218-218-1
|
2082-81-7
|
ECHA
|
Under development
|
Other action
|
08-jul.-2021
|
Details | ||
244-121-9
|
20941-65-5
|
ECHA
|
Under development
|
Other action
|
24-jun.-2021
|
Details | ||
216-768-7
|
1663-39-4
|
ECHA
|
Under development
|
Other action
|
08-jul.-2021
|
Details | ||
425-060-9
|
-
|
ECHA
|
Under development
|
CLH Other action |
16-dec.-2021
|
Details | ||
931-185-4
|
-
|
ECHA
|
Concluded
|
Other action
|
19-nov.-2021
|
Details | ||
237-272-7
|
13718-26-8
|
ECHA
|
Under development
|
CLH Other action |
19-maj-2021
|
Details | ||
231-209-7
|
7446-81-3
|
ECHA
|
Under development
|
Other action
|
08-jul.-2021
|
Details | ||
941-802-9
|
-
|
ECHA
|
Concluded
|
Other action
|
19-nov.-2021
|
Details | ||
941-992-3
|
-
|
ECHA
|
Under development
|
Other action
|
16-dec.-2021
|
Details | ||
940-894-8
|
-
|
ECHA
|
Concluded
|
Other action
|
19-nov.-2021
|
Details | ||
941-211-6
|
-
|
ECHA
|
Under development
|
CCH Other action |
04-mar.-2021
|
Details | ||
943-265-6
|
-
|
ECHA
|
Under development
|
Other action Other action |
16-dec.-2021
|
Details | ||